Free Trial

Zacks Research Estimates Itron's Q1 Earnings (NASDAQ:ITRI)

Itron logo with Computer and Technology background

Itron, Inc. (NASDAQ:ITRI - Free Report) - Analysts at Zacks Research decreased their Q1 2027 earnings per share (EPS) estimates for Itron in a report issued on Wednesday, October 15th. Zacks Research analyst Team now expects that the scientific and technical instruments company will post earnings of $1.69 per share for the quarter, down from their previous estimate of $1.70. Zacks Research has a "Strong-Buy" rating on the stock. The consensus estimate for Itron's current full-year earnings is $5.33 per share.

ITRI has been the topic of several other reports. Weiss Ratings reissued a "buy (b)" rating on shares of Itron in a research report on Wednesday, October 8th. Johnson Rice lowered Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Wall Street Zen raised Itron from a "hold" rating to a "buy" rating in a research report on Friday, October 3rd. Guggenheim reaffirmed a "buy" rating and issued a $155.00 target price (up from $133.00) on shares of Itron in a research report on Monday, July 14th. Finally, Stephens reaffirmed an "equal weight" rating and issued a $130.00 target price on shares of Itron in a research report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Itron currently has an average rating of "Moderate Buy" and a consensus price target of $138.10.

Get Our Latest Stock Analysis on Itron

Itron Stock Up 0.4%

NASDAQ:ITRI opened at $134.25 on Friday. The firm has a market capitalization of $6.14 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 0.73 and a beta of 1.48. Itron has a 1-year low of $90.11 and a 1-year high of $140.04. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. The business's fifty day moving average price is $123.96 and its 200 day moving average price is $120.50.

Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.29. The firm had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.Itron's quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS.

Insider Activity at Itron

In other news, SVP Justin K. Patrick sold 388 shares of the company's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $48,620.28. Following the completion of the sale, the senior vice president owned 20,761 shares in the company, valued at approximately $2,601,560.91. This represents a 1.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP John F. Marcolini sold 565 shares of the company's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the sale, the senior vice president owned 14,396 shares of the company's stock, valued at approximately $1,803,962.76. This trade represents a 3.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 3,037 shares of company stock worth $380,566 in the last 90 days. Insiders own 1.45% of the company's stock.

Institutional Trading of Itron

Several large investors have recently made changes to their positions in ITRI. SG Americas Securities LLC boosted its stake in shares of Itron by 398.8% during the 1st quarter. SG Americas Securities LLC now owns 6,833 shares of the scientific and technical instruments company's stock worth $716,000 after acquiring an additional 5,463 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in Itron by 0.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 16,795 shares of the scientific and technical instruments company's stock valued at $1,759,000 after purchasing an additional 121 shares during the period. Sowell Financial Services LLC acquired a new stake in Itron in the 1st quarter valued at approximately $266,000. Illumine Investment Management LLC grew its holdings in Itron by 3.6% in the 1st quarter. Illumine Investment Management LLC now owns 7,227 shares of the scientific and technical instruments company's stock valued at $757,000 after buying an additional 252 shares during the last quarter. Finally, Asset Management One Co. Ltd. acquired a new stake in Itron in the 1st quarter valued at approximately $320,000. Institutional investors own 96.19% of the company's stock.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Articles

Earnings History and Estimates for Itron (NASDAQ:ITRI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.